CAMP4 Therapeutics Corporation(CAMP)

Biotechnology · Cambridge, MA

$4.01+0.01 (+0.25%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T12:50:52.811Z.

Stored calculation inputs

Calculation as of: 2026-10-06T12:50:52.811Z.

Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -2.23
Quote price: 4.01

FMP input reference: 5c882cca81b2c0fe2c09916b57b0a50c93804d18514abf2397940823ad07c5bd

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

CAMP Earnings Yield Metrics

EARNINGS YIELD

N/A

CAMP Competitors' Earnings Yield

CAMP

CAMP4 Therapeutics Corporation

Current

Market Cap

$251.64M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GLSI

Greenwich LifeSciences, Inc.

vs CAMP

Market Cap

$248.21M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IFRX

InflaRx N.V.

vs CAMP

Market Cap

$247.45M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GALT

Galectin Therapeutics Inc.

vs CAMP

Market Cap

$245.65M

Earnings Yield

N/A

TTM Avg

37.01%

3Y Avg

37.01%

5Y Avg

37.01%

AKBA

Akebia Therapeutics, Inc.

vs CAMP

Market Cap

$244.25M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EPRX

Eupraxia Pharmaceuticals Inc.

vs CAMP

Market Cap

$259.30M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HITI

High Tide Inc.

vs CAMP

Market Cap

$239.89M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BIOA

BioAge Labs Inc.

vs CAMP

Market Cap

$239.45M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ANIK

Anika Therapeutics, Inc.

vs CAMP

Market Cap

$264.05M

Earnings Yield

N/A

TTM Avg

1.20%

3Y Avg

4.13%

5Y Avg

3.97%

IKT

Inhibikase Therapeutics, Inc.

vs CAMP

Market Cap

$264.07M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
CAMP4 Therapeutics Corporation (CAMP)	$251.64M	N/A	N/A	N/A	N/A
Greenwich LifeSciences, Inc. (GLSI)vs ›	$248.21M	N/A	N/A	N/A	N/A
InflaRx N.V. (IFRX)vs ›	$247.45M	N/A	N/A	N/A	N/A
Galectin Therapeutics Inc. (GALT)vs ›	$245.65M	N/A	37.01%	37.01%	37.01%
Akebia Therapeutics, Inc. (AKBA)vs ›	$244.25M	N/A	N/A	N/A	N/A
Eupraxia Pharmaceuticals Inc. (EPRX)vs ›	$259.30M	N/A	N/A	N/A	N/A
High Tide Inc. (HITI)vs ›	$239.89M	N/A	N/A	N/A	N/A
BioAge Labs Inc. (BIOA)vs ›	$239.45M	N/A	N/A	N/A	N/A
Anika Therapeutics, Inc. (ANIK)vs ›	$264.05M	N/A	1.20%	4.13%	3.97%
Inhibikase Therapeutics, Inc. (IKT)vs ›	$264.07M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Earnings Yield: N/A

CAMP Earnings Yield Metrics

CAMP Competitors' Earnings Yield

Earnings Yield vs P/E Ratio

Earnings Yield Formula & Definition

Related Metrics